| Description | Pivampicillin, a pivalate ester analog of Ampicillin, is used to treat chronic obstructive pulmonary disease (COPD) in children and young adults. |
| molecular weight | 463.55 |
| Molecular formula | C22H29N3O6S |
| CAS | 33817-20-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: Soluble |
| References | 1. Winther L, Baptiste KE, Friis C. Pharmacokinetics in pulmonary epithelial lining fluid and plasma of ampicillin and pivampicillin administered to horses. Res Vet Sci. 2012 Feb;92(1):111-5. doi: 10.1016/j.rvsc.2010.11.001. Epub 2010 Dec 7. PubMed PMID: 21144541. 2. Johansen HK, Børch K, Espersen F, Koch C, Høiby N. Randomised trial of pivampicillin plus pivmecillinam vs. pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae. Curr Med Res Opin. 1999;15(4):300-9. PubMed PMID: 10640263. 3. Bukh N. Double-blind comparison of pivmecillinam plus pivampicillin ('Miraxid') with pivampicillin alone in chronic bronchitis: a Danish multi-centre study. Pharmatherapeutica. 1983;3(6):422-8. PubMed PMID: 6312461. 4. Hey H, Matzen P, Andersen JT, Didriksen E, Nielsen B. A gastroscopic and pharmacological study of the disintegration time and absorption of pivampicillin capsules and tablets. Br J Clin Pharmacol. 1979 Sep;8(3):237-42. PubMed PMID: 497090; PubMed Central PMCID: PMC1429802. |